Skip to main content
AUTOBIO DIAGNOSTICS CO., LTD logo

AUTOBIO DIAGNOSTICS CO., LTD — Investor Relations & Filings

Ticker · 603658 ISIN · CNE100002GC4 LEI · 300300HTZSCUCA32U369 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 1,290 across all filing types
Latest filing 2020-10-29 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 603658

About AUTOBIO DIAGNOSTICS CO., LTD

https://en.autobio.com.cn/

Autobio Diagnostics Co., Ltd. specializes in the research, development, manufacturing, and distribution of comprehensive in vitro diagnostic (IVD) solutions. The company offers an extensive portfolio of products across multiple clinical disciplines, including immunoassay, microbiology, and molecular diagnostics. Key offerings include high-throughput chemiluminescence immunoassay (CLIA) systems, enzyme-linked immunosorbent assay (ELISA) kits, and automated microbiology platforms for blood culture and microbial identification. Autobio also provides integrated laboratory automation systems designed to enhance diagnostic efficiency and accuracy. By focusing on technological innovation and quality, the company serves clinical laboratories, hospitals, and medical institutions worldwide, supporting the detection of infectious diseases, oncology markers, and various metabolic disorders.

Recent filings

Filing Released Lang Actions
第三届监事会第十七次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a resolution announcement from the Supervisory Board of Zhengzhou Antu Bioengineering Co., Ltd. regarding the approval of the 2020 third quarter report and other related matters. It mentions the review and approval of the third quarter report but does not contain the report itself, only stating that the report details are disclosed on the Shanghai Stock Exchange website. The document also includes approval of matters related to the opening of a special account for non-public stock issuance funds and signing of supervision agreements. The document length is short (1360 characters) and serves as an official announcement of meeting resolutions rather than the full quarterly report. Therefore, it is best classified as a Regulatory Filing (RNS) because it is a formal announcement of supervisory board resolutions and related regulatory compliance matters, not the actual interim/quarterly report (IR).
2020-10-29 Chinese
2020年第三季度报告正文
Interim / Quarterly Report Classification · 100% confidence The document is titled '2020年第三季度报告' which translates to '2020 Third Quarter Report'. It contains detailed financial data including balance sheet items, profit and loss items, cash flow statements, and shareholder information for the third quarter of 2020. The document is 7139 characters long, which is substantial and contains actual financial statements and analysis for a period shorter than a full fiscal year. It is explicitly described as a quarterly report and includes management assurances about the accuracy of the financial data. Therefore, this document fits the definition of an Interim / Quarterly Report (IR).
2020-10-29 Chinese
关于二级子公司取得《药品经营许可证》的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement regarding a subsidiary obtaining a pharmaceutical business license. It contains no financial data, no report or financial results, and no mention of meetings or votes. It is an official company announcement about a regulatory approval/license. The document length is only 643 characters, indicating it is a brief announcement rather than a full report. This fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2020-10-20 Chinese
关于全资子公司医疗器械生产许可证变更登记的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the change in registration of a medical device production license for a wholly-owned subsidiary of the company. It details the updated production address and license information but does not contain financial data, management changes, or regulatory filings related to financial performance. It is a regulatory announcement about operational licensing, not a financial report or management change. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2020-10-20 Chinese
控股股东减持股份结果公告
Major Shareholding Notification Classification · 100% confidence The document is a formal announcement regarding the results of a shareholding reduction by the controlling shareholder of the company. It details the number of shares held before and after the reduction, the percentage of total shares, the methods of reduction, and confirms that the reduction plan has been completed. There is no financial statement, audit, or management discussion present. The document is a regulatory announcement about a major shareholder's transaction, specifically a reduction in shareholding. This fits the category of Major Shareholding Notification (MRQ). The document length is short and focused solely on shareholding changes, not a full report or earnings release.
2020-09-29 Chinese
关于非公开发行股票申请获得中国证监会核准批复的公告
Capital/Financing Update Classification · 100% confidence The document is an announcement from Zhengzhou Antu Bioengineering Co., Ltd. regarding the approval from the China Securities Regulatory Commission (CSRC) for a non-public issuance of shares. It details the approval, the number of shares to be issued, validity period, and compliance requirements. This is clearly an update on the company's capital raising activity through share issuance. It is not a full financial report, audit, or management discussion, nor is it a voting result or legal proceeding. The document is short (849 characters) and focused on capital issuance approval, fitting the Capital/Financing Update category.
2020-09-09 Chinese

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.